REMYGEN Trademark

Trademark Overview

On Wednesday, July 12, 2017, a trademark application was filed for REMYGEN with the United States Patent and Trademark Office. The USPTO has given the REMYGEN trademark a serial number of 87524598. The federal status of this trademark filing is REGISTERED as of Tuesday, February 1, 2022. This trademark is owned by Diamyd Medical AB. The REMYGEN trademark is filed in the Pharmaceutical Products category with the following description:

Anti-diabetic pharmaceuticals all in the nature of pharmaceutical preparations for the prevention and treatment of diabetes; Anti-diabetic preparations all in the nature of pharmaceutical preparations for the prevention and treatment of diabetes; Pharmaceutical preparations for treating diabetes
remygen

General Information

Serial Number87524598
Word MarkREMYGEN
Filing DateWednesday, July 12, 2017
Status700 - REGISTERED
Status DateTuesday, February 1, 2022
Registration Number6630983
Registration DateTuesday, February 1, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 16, 2021

Trademark Statements

Goods and ServicesAnti-diabetic pharmaceuticals all in the nature of pharmaceutical preparations for the prevention and treatment of diabetes; Anti-diabetic preparations all in the nature of pharmaceutical preparations for the prevention and treatment of diabetes; Pharmaceutical preparations for treating diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 18, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDiamyd Medical AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressStockholm 11156
SE
Party NameDiamyd Medical AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressStockholm 11156
SE
Party NameDiamyd Medical AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressStockholm 11156
SE

Trademark Events

Event DateEvent Description
Tuesday, February 1, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, November 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 16, 2021PUBLISHED FOR OPPOSITION
Wednesday, October 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 14, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 13, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 13, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 13, 2021ASSIGNED TO LIE
Thursday, October 7, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 7, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 7, 2021NON-FINAL ACTION E-MAILED
Wednesday, April 7, 2021NON-FINAL ACTION WRITTEN
Thursday, March 18, 2021CASE RETURNED TO EXAMINATION
Monday, January 11, 2021NOTICE OF ALLOWANCE CANCELLED
Wednesday, March 17, 2021PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Friday, February 26, 2021NOTICE OF REINSTATEMENT E-MAILED
Monday, February 22, 2021REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
Tuesday, February 16, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 15, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 26, 2021TEAS RESPONSE TO PETITION TO DIRECTOR INQUIRY
Monday, January 25, 2021PETITION INQUIRY LETTER ISSUED
Monday, January 25, 2021TEAS RESPONSE TO PETITION TO DIRECTOR INQUIRY
Thursday, January 7, 2021ASSIGNED TO PETITION STAFF
Tuesday, January 5, 2021TEAS PETITION TO AMEND BASIS RECEIVED
Friday, July 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 23, 2020EXTENSION 5 GRANTED
Monday, July 6, 2020EXTENSION 5 FILED
Thursday, July 23, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 6, 2020TEAS EXTENSION RECEIVED
Friday, December 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 18, 2019EXTENSION 4 GRANTED
Wednesday, December 18, 2019EXTENSION 4 FILED
Wednesday, December 18, 2019TEAS EXTENSION RECEIVED
Wednesday, July 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 8, 2019EXTENSION 3 GRANTED
Monday, July 8, 2019EXTENSION 3 FILED
Monday, July 8, 2019TEAS EXTENSION RECEIVED
Friday, January 4, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 2, 2019EXTENSION 2 GRANTED
Wednesday, January 2, 2019EXTENSION 2 FILED
Wednesday, January 2, 2019TEAS EXTENSION RECEIVED
Wednesday, May 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 30, 2018EXTENSION 1 GRANTED
Monday, April 30, 2018EXTENSION 1 FILED
Monday, April 30, 2018TEAS EXTENSION RECEIVED
Tuesday, January 9, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 14, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 14, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 25, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 11, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 11, 2017ASSIGNED TO EXAMINER
Tuesday, July 18, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 15, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

remygen preparations diabetes pharmaceutical treatment diabetic nature prevention anti treating pharmaceuticals